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This study explored the genetic diversity of Mycobacterium tuberculosis isolates in Iraq by
spoligotyping and 15-locus-based mycobacterial interspersed repetitive unit-variable num-
ber tandem repeat (MIRU-VNTR) methods. Initially, 270 isolates from 134 patients were col-
lected and then 134 non-duplicating isolates (1 isolate/patient) were subjected to the study
analyses, 70 isolates were found to be multidrug resistant (MDR) upon testing by proportion
method on Lo¨wenstein–Jensen medium.
Spoligotyping yielded 39 patterns; 111/134 (82.2%) isolates being grouped in 16 clusters vs.
23/134 (17.2%) isolates being unique. SIT1144/T1 represented the largest cluster (n = 20,
14.9%), followed by SIT25/CAS1_Delhi (n = 19, 14.2), SIT22/CAS1_Delhi (n = 12, 9%); the other
clusters ranged from 2 to 8 isolates. The SIT1144 is not reported in neighboring countries
and only 4 isolates were reported worldwide (2 in USA, 1 in Venezuela, and 1 in Greece).
This study reported 4 isolates belonging to SIT41/Turkey family, and thus it seems that this
family is not exclusive to Turkey as previously thought. CAS lineage was predominant in
this study (42.5%), followed by ill-defined T (29.9%).
Highly diverse MIRU-VNTR genotypes were displayed; 100 distinct MIRU-VNTR genotypes
were detected (8 clusters with 2–8 strains/cluster and 92 unique). The clustering rate was
18.03%. The discriminatory efficiency of MIRU-VNTR was high (Hunter-Gaston discrimina-
tory index [HGDI] = 0.992); it was higher than that of spoligotyping (HGDI; 0.930). However,
the highest discriminatory power was provided by spoligotyping and MIRUs together.
Owing to the low clustering rate by MIRU-VNTR, these results suggest that drug-resistance
TB in Iraq is due to acquired resistance as opposed to transmission.
Conclusion: Iraq is specific in having its own most predominant lineage (SIT1144/T1) which
is not found among neighboring countries. The 15-locus MIRU-VNTR can be useful in dis-
criminating M. tuberculosis isolates in Iraq.
 2014 Published by Elsevier Ltd. on behalf of Asian-African Society for Mycobacteriology.
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Infection with Mycobacterium tuberculosis is responsible for
extensive morbidity and mortality worldwide with approxi-
mately 8.8 million new cases and 1.1 million deaths reported
in the year 2010 [1]. The importance of TB as a major public
health problem has dramatically escalated with the emer-
gence of the multi-drug resistant tuberculosis (MDR-TB),
defined as a combined resistance to Rifampicin and Isoniazid
[2].
Iraq is one of the countries with the highest incidence
among the Eastern Mediterranean region with TB accounting
for 56/100,000 population, and the estimated MDR-TB cases
among new pulmonary TB cases notified in 2010 is 210
(50–380), whereas the estimated number among retreated
pulmonary cases is 160 (57–260) [3]. These data are being
extracted from the cases registration system that is based
on clinical findings and microscopy. In the last few decades,
Iraq has witnessed political instabilities and consecutive wars
that left their marks on the health system. Unfortunately,
there is no reliable study yet conducted to figure out the
impact of those conditions on TB epidemiology in this coun-
try. Although genotyping of M. tuberculosis is currently appre-
ciated as a significant complement for TB control programs
[4–8], very limited data are available on the genotypes of
MTB strains circulating in Iraq [9]. In contrast, in the last
few years, several studies were published describing the
genotypes of MTB strains isolated in neighboring countries
such as Turkey, Iran and Saudi Arabia [10–15].
This study sought to conduct a molecular study to
explore the genetic diversity and M. tuberculosis isolates in
Iraq. Its aim was to shed some light on the population
structure of MTB strains in Iraq and its comparison with that
in the neighboring countries. It is believed that conducting
such a study would generate a sort of data that may
eventually lead to a better understanding of tuberculosis epi-
demiology in Iraq, especially the transmission dynamic of
this microorganism. Although IS6110-RFLP has been
considered the golden standard for studying the molecular
epidemiology of M. tuberculosis, its use has been limited
[16]. Alternatively, use of PCR-based genotyping methods like
spoligotyping and Mycobacterial Interspersed Repetitive
Units-Variable Tandem Repeats (MIRU-VNTR) have gained
wide appreciation due to simplicity, rapid availability of
results, reproducibility and possibility of digitizing data and
exchange for inter-laboratories communications and
comparisons [17].
In this study it is believed that spoligotyping and MIRU-
VNTR genotyping methods present the largest amount of
molecular epidemiology data on M. tuberculosis from Iraq to
date.
Materials and methods
Ethics statement
This study was approved by the Ethics Committee of the
Iraqi Ministry of Health and was performed in accordance
with all national regulations. Nonetheless, since themycobacterial isolates were collected from patients’ routine
samples, this study was considered a laboratory study and
ethics approval was not required. Although it was a retro-
spective study, anonymity of the patients were maintained
through using a special coding system based on numbers
to ensure that this study would have no chance to affect
the patient’s welfare.
Mycobacterial clinical isolates and DNA extracts
During the period from January 2011 to July 2012, initially all
culture positive M. tuberculosis isolates (more than 270 iso-
lates) were collected and isolated from Iraqi patients with
active pulmonary tuberculosis that attended the National
Reference Laboratory of the National Center of Tuberculosis
and chest illnesses (NTP – Iraq). Because of that this labora-
tory is the only lab across Iraq accredited with performing
culture and drug susceptibility testing; there was a referral
bias towards treatment failure. The isolates were identified
as M. tuberculosis according to standard phenotypic criteria.
Testing of drug susceptibility of these isolates to four first-line
anti-TB drugs (Rifampin, Isoniazid, Streptomycin, and
Ethambutol) was performed by agar proportional method on
Lowenstein–Jensen media as described elsewhere (WHO,
2008). Among the 270 isolates, there were multiple isolates
from the same patients, recovered on different visits to the
laboratory. As all of the multiple isolates/patients gave the
same profile on Spoligotyping and MIRU-VNTR, one isolate
per patient was selected. Thus, 134 non-duplicated M. tubercu-
losis culture isolates (1 isolate/patient) were obtained that
were subjected for the study analyses later on. Mycobacterial
genomic DNA was extracted from cultured cells as described
previously (13, 14, 15).
Genotyping of the isolates
The isolates were characterized by two genotyping
methods, spoligotyping and MIRU-VNTR. Spoligotyping
was performed as previously described [18]. MIRU-VNTR
genotyping was performed by PCR-amplification of a panel
of 15 MTB MIRU loci using primers described in the MIRU-
VNTR standard protocol [17]. Mycobacterium bovis P3 and
H37Rv were used as positive controls and autoclaved with
double distilled water as a negative control. The results
were compared with updates of the international spoligo-
type database of the Pasteur Institute of Guadeloupe which
provides information on the shared-type distribution of M.
tuberculosis spoligotypes at the worldwide level [18]. At the
time of the comparison, the updated SITVIT2 version con-
tained more than 90,000 patterns from more than 160 coun-
tries of patient origin.
MIRU-VNTR profile matching a pre-existing profile was
classified as MIRU-VNTR international type (MIT). Newly cre-
ated MIT results either after matching of an orphan profile in
the study with another orphan profile present in the database
or when two or more isolates within the study had the same
new MIRU-VNTR profile. Additionally, MIRU-VNTR clusters
arise when two or more isolates within the study had an
identical profile.
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Data obtained from spoligotyping and MIRU-VNTR were used
to construct a minimum spanning trees (MSTs) with the Bio-
Numerics software version 3.5 (Applied Maths, Sint-Martens-
Latem, Belgium), and Spoligoforests with SpolTools software
(available at: http://www.emi.unsw.edu.au/spolTools).
Spoligoforests were drawn as directed and not necessarily
connected graphs using a hierarchical layout and a Fruch-
terman-Reingold algorithm to determine the parent to descen-
dant links between the spoligotype patterns. Contrarily to the
Spoligoforests, MSTs are connected undirected graphs which
link all the strains together with the fewest possible linkages
between nearest neighbors. MSTs have been constructed with
spoligotype patterns as well as MIRU-VNTR patterns.
The discriminatory power and allelic diversity were calcu-
lated using h value and Hunter Gaston Discriminatory Index
(HGDI) using the equations: h = 1  Rxi2 where xi is the fre-
quency of the ith allele at each locus [19,20].
HGDI ¼ 1  1NðN1Þ
Ps
j¼1njðnj  1Þ where N: is the total num-
ber of isolates, s: is the total number of different patterns,
and nj: is the number of isolates belonging to the jth pattern
[21].
The mean of allelic diversity of the MIRU-VNTR method
was calculated from the formula: H = Rh/n where the h is
the allelic diversity and n: is the number of loci [22].
Clustering rate was calculated using the formula (nc  c)/n
where the nc: is the total number of clustered cases, c: is the
number of clusters, n: is the total number of cases in the study
[23].
MIRU-VNTR profile of MDR, CAS and ill-defined T lineages
were further analyzed separately using non-parametric
Mann–Whitney test [24].
Results
Patients
Spoligotypes and the 15-locus MIRU-VNTR genotypes were
fully conserved among the multiple isolates per single
patient. In contrast, different patients displayed diverse spoli-
gotypes and MIRU-VNTR genotypes. Therefore, in case of
availability of multiple isolates from a single patient, only
one isolate per patient was selected and considered in the
study analyses. Thus, a total of 134 non-duplicating M. tuber-
culosis isolates from conveniently-selected different patients
were included; 77 patients (57.9%) were resident in Baghdad,
while the rest (42.1%) were living in different provinces and
regions of Iraq. More males (91) than females (43) were seen
in this study (male to female ratio was 2.1 to 1). The mean
age of patients was 36.29 years. Nevertheless, males were
slightly older than females (mean age of males and females
were 38.89 and 31.55 years, respectively). Phenotypic Drug
susceptibility testing (DST) based on agar proportional
method detected multi-drug resistance in 70 (52.2%) cases.
A significant association was found between gender
(P = 0.02) and drug resistance, females being associated with
MDR. Because the isolates were collected from a reference
laboratory with a relatively higher proportion of previouslytreated patients (chronic TB cases), sampling bias cannot be
ruled out, and this data may overestimate the percentage of
MDR-TB in Iraq.
Spoligotyping analysis
Reproducible spoligotype profiles were obtained from all the
134 isolates. The spoligotype profiles obtained were compared
using the SITVIT2 database, and the strain lineages were
identified. In this database, SIT (shared international type)
designate spoligotype patterns shared by two or more
patients’ isolates, whereas ‘‘orphan’’ designates patterns
reported for a single isolate.
The description of spoligotype patterns observed among
the 134 isolates, corresponding Spoligotype International
Type (SIT) designations, genotypic lineages, and their world-
wide distribution in the SITVIT2 database is summarized in
Table 1. Spoligotyping yielded 39 patterns; 111/134 (82.2%)
were grouped in 16 clusters vs. 23/134 (17.2%) isolates that
were unique. Comparing results with the international data-
base categorized 128 (95.5%) isolates in 34 shared types (33
were preexisting and one was newly created after matching
with an orphan strain from Iran) and 5 isolates as orphans;
82.8% of the strains were grouped into 16 SITs: SIT1144/T1
represented the largest cluster (n = 20, 14.9%), followed by
SIT25/CAS1_Delhi (n = 19, 14.2), SIT22/CAS1_Delhi (n = 12,
9%), SIT26/CAS1_Delhi (n = 8, 6%), SIT284/T1 (n = 7, 5.2%), 3
clusters each contained 6 strains (4.5%); SIT1198/CAS1_Delhi,
SIT50/H3, SIT54/MANU2, one cluster contained 5 strains
(3.7%); (SIT247/CAS1_Delhi, 4 clusters each contained 4
strains (3%); SIT53/T1, SIT47/H1, SIT127/H4(Ural-2), SIT41/Tur-
key, and 2 clusters each contained 2 strains (1.5%); SIT29/LAM
and SIT 3371/CAS1_Delhi. Around 60%, 83%, and 75% of
strains belong to SIT1144, SIT25, SIT53, respectively, and were
from young patients (below 35 years). No association was
found between gender and shared types or clusters.
Comparing the distribution of the spoligotype patterns
reported in this study with strain isolates in neighboring coun-
tries revealed several notable findings (Supplement Table S2);
SIT1144/T1, the predominant Spoligotype in Iraq (n = 20,
14.93% of all cases) is not recorded in any of the neighboring
countries, and it showed the following distribution pattern in
SITVIT2 database (n = 24 strains in total: Iraq n = 20, USA
n = 2, Venezuela n = 1, Greece n = 1), the distribution proportion
of SIT127/(H4/Ural-2) sublineage is 17% in Iran, 3% in Iraq, and
0.7% in Saudi Arabia (0.66%), thus, SIT127 may have dispersed
first in Iran, followed by Iraq, and Saudi Arabia. Considering
the total number of SIT284 strains in SITVIT2 database
(n = 167), the global proportion of those strains is more predom-
inant in Bulgaria (23.95%), followed by Turkey (20.96%) and
Saudi Arabia (13.77%). However, this new Iraqi study revealed
that, considering the proportion of SIT number per country,
SIT284 is present in Iraq in a greater proportion than its neigh-
boring countries. In addition, this study showed that there are
other similar lineages in circulation among Iraq, Iran, Saudi
Arabia and Turkey, such as CAS1_delhi.
Distribution of spoligotype lineages and sublineages in
this study is summarized in Table 2. It is noteworthy that
92.6% of all M. tuberculosis were attributed to 4 lineages,
Table 1 – The description of spoligotype patterns observed among the 134 isolates, corresponding Spoligotype International
Type (SIT) designations, genotypic lineages, and their worldwide distribution in the SITVIT2 database.
*A total of 33/34 SITs matched a preexisting shared-type in the database, whereas 1 SIT (SIT3776*, n = 1 isolate) was newly created after a match
with an orphan strain from Iran. Note that orphan patterns (n = 5) are shown at the bottom of the table, and mentioned as Orph 1–5, which
correspond to the following strain numbers: Orph 1 (3284); Orph 2 (5760); Orph 3 (5953); Orph 4 (6005); Orph 5 (6320).
**Clade designations according to SITVIT2 using revised SpolDB4 rules; ‘‘Unknown’’ designates patterns with signatures that do not belong to any
of the major clades described in the database.
***Clustered strains correspond to a similar spoligotype pattern shared by 2 or more strains ‘‘within this study’’; as opposed to unique strains
harboring a spoligotype pattern that does not match with another strain from this study. A unique strain matching a preexisting pattern in the
SITVIT2 database is classified as SIT, whereas in case of no match, it is designated as ‘‘Orphan’’ (n = 5, shown at the bottom part of the Table).
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Table 2 – Distribution of spoligotype lineage and sublin-
eages in this study.
M. tuberculosis lineages Sublineage No. of isolates (%)
CAS CAS 1 (0.75)
CAS1-Delhi 56 (41.80)
Haarlem H1 5 (3.73)
H3 8 (5.97)
H3/H4 (Ural-1)* 1 (0.75)
H4/Ural-2* 5 (3.73)
LAM LAM 2 (1.49)
LAM6 1 (0.75)
MANU MANU2 8 (5.975)
S 1 (0.75)
T T 1 (0.75)
T1 36 (26.8)
T2 1 (0.75)
T3 2 (1.49)
Turkey Turkey* 4 (2.98)
Unknown Unknown 2 (1.49)
X X1 1 (0.75)
Total 134 (100)
* Note that, (i) H3/H4-Ural-1 and H4/Ural-2 are now considered as
‘‘Ural lineage’’; (ii) the Turkey lineage was previously referred to as
LAM7-TUR.
Table 3 – Distribution of MDR cases according to the SITs.
SIT MDR Total
Non-MDR MDR
SIT Orphan 3 1 4
22 4 8 12
25 13 6 18
26 5 3 8
29 0 2 2
34 0 1 1
36 1 0 1
37 1 1 2
41 1 3 4
46 0 1 1
47 4 0 4
49 0 1 1
50 0 6 6
53 3 1 4
54 7 1 8
62 1 0 1
64 1 0 1
86 0 1 1
102 0 1 1
127 2 2 4
247 1 4 5
284 3 4 7
516 1 0 1
520 0 1 1
704 1 0 1
777 0 1 1
878 1 0 1
954 0 1 1
1144 2 18 20
1198 6 0 6
1789 1 0 1
2145 0 1 1
2230 1 0 1
3371 1 1 2
3776 1 0 1
Total 64 70 134
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that could be split in Haarlem sensu-stricto, 9.7%; and Ural
4.48%, since H3/H4-Ural-1 and H4/Ural-2 are now considered
as ‘‘Ural lineage’’), and MANU (6%).
Table 3 summarizes the distribution of the MDR strains
according to shared types. Amongst the 70 MDR strains, 24
spoligotyping patterns were identified; 56 isolates (80%) were
grouped into 10 clusters (2–18 isolates/clusters), and 14 were
unique. The clustering rate was 65.7%, which was comparable
to that in the whole set of isolates in this study. Amongst the 70
MDR strains, the clustering rate was 65.7%, which was compa-
rable to the whole study set of isolates. The SIT1144/T1 was
over-represented amongst the MDR isolates comprising
around one quarter (25.7%, n = 18) of the total MDR cases and
thus 90% of all SIT1144 strains were MDR. Therefore, it seems
that this SIT has a great propensity to be MDR. In addition, 8/
12 of SIT22/CAS1_Delhi strains (66.7%) were MDR comprising
11.4% of total MDR cases. Furthermore, 6/6 (100%) of SIT50/H3
and 4/5 (80%) of SIT247/CAS1_Delhi strains were MDR. The
remaining MDR strains were as follows: 4/7 SIT284 (5.7%), 3/8
SIT26 (4.2%), 3/4 SIT41 (4.2%), 2/2 SIT29 (2.8%) and 2/4 SIT127
(2.8%). On the contrary, certain SITs showed the opposite trend,
where 4/4 of the SIT47/H1 strains were non-MDR.
Construction of spoligoforest graphs
For visualizing the relationships among genotypes of tubercu-
losis strains in this study, a spoligoforest was constructed
using the application available in the spolTools website
http://www.emi.unsw.edu.au/spolTools (Fig. 1). Information
concerning the age of a spoligotype is manifested in three
attributes of a spoligoforest. First, the larger the node size,
the longer the time over which strain with that spoligotype
has been extensively transmitted. Second, the larger number
of descendant (outbound edges), the longer period the strainhas to generate mutations. Third, the position of the node
gives evidence on the age of the spoligotype–the closer it is
to the root node, the older it is.
Note that the meaning/significance of the links/edges is
the same for Hierarchical Layout and Fruchterman–Reingold
trees. Solid black lines link patterns with a maximum weight
of distance (very similar: loss of one spacer). Dashed lines rep-
resent a link of weight comprised between 0.5 and 1, and dot-
ted lines represent a link of weight less than 0.5.
In both trees, one can denote that SIT1144 (T1) is the big-
gest and more visible node (n = 20). SIT25 (CAS1-Delhi) repre-
sents the second biggest node (n = 19). The 3 following
predominant nodes are constituted by SIT22/CAS1_Delhi
(n = 12), SIT26/CAS1_Delhi (n = 8), and SIT284/T1 (n = 7).
MIRU-VNTR
Among the 134 M. tuberculosis non-duplicating isolates, 122
showed amplification products of the 15 loci MIRU-VNTR,
whereas 12 isolates had incomplete or no MIRU-VNTR profiles
even after repeating the test. Highly diverse MIRU-VNTR
genotypes were displayed; 100 distinct MIRU-VNTR genotypes
Fig. 1 – The spoligoforest trees drawn using http://www.emi.unsw.edu.au/spolTools/. The trees represent each spoligotype
pattern by a node with area proportional to the number of isolates with that spoligotype pattern. Changes (loss of spacers) are
represented by directed edges between nodes, with the arrowheads pointing to descendant spoligotypes. (A). The
Hierarchical Layout represents hierarchically the changes between MTBC spoligotypes. The more the strains evolve (lose
spacers), the more they are present in the down layouts. Thus the patterns which have not lost many alleles/spacers are
located in the upper layouts as opposed to those which have lost more spacers (and are located in the down layouts). When
there are too many changes between the patterns of spoligotype, there are no links/edges linking them. (B). The
Fruchterman–Reingold trees use a force-based algorithm to position the nodes of a graph in a two-dimensional or three-
dimensional space so that all the edges are of more or less equal length and there are as few crossing edges as possible. Thus
the nodes containing a huge number of strains are centered and are more visible in the figure.
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orphan genotypes (unique). The clustering rate was 18.03%
(Supplemental Table S1).
The largest cluster defined by 15-MIRU-VNTR (n = 8)
was MIT230 (342442442273433); followed by MIT221
(522364326235447) (n = 5). The MIT222 and MIT231 clusters
each included 4 strains; the MIT 223 cluster included 3 strains.
The MIT228, MIT229, MIT232, clusters each with 2 strains per
cluster. Noteworthy: the majority of strains within every
MIRU cluster were isolated in the same geographic region;
this may imply an epidemiological link. Of note, in most ofthe clusters, the strains were from Baghdad. This may be
because Baghdad is the most populated province amongst
the 18 provinces of Iraq (being inhabited by almost one third
of the total Iraqi population).
Allelic diversity
The results of allelic diversity and the Hunter-Gaston Diversity
Index (HGDI) for all strains are summarized in Table 4, whereas
Table 5 summarizes the HGDIs for CAS and T strains, in addi-
tion to the MDR strains. HGDI of all strains revealed that the
Table 4 – Distribution of 122 M. tuberculosis containing variable numbers of each MIRU-VNTR locus and allelic diversity.
Loci Frequency at each locus Allelic Diversity (HGDI) Conclusion*
1 2 3 4 5 6 7 8 9
MIRU4 5 115 1 1 0.10 Poorly discriminate
MIRU10 10 19 29 33 23 7 1 0.82 Highly discriminate
MIRU16 4 22 37 53 2 4 0.69 Highly discriminate
MIRU26 7 10 3 43 10 44 3 2 0.73 Highly discriminate
MIRU31 6 60 3 50 3 0.59 Moderately discriminate
MIRU40 3 19 57 34 1 1 0.69 Highly discriminate
ETRA 3 47 34 28 2 6 0.74 Highly discriminate
ETRC 56 21 40 3 0.67 Highly discriminate
Qub11b 75 5 23 3 3 6 0.66 Highly discriminate
Qub26 2 12 47 50 8 4 0.68 Highly discriminate
Qub4156 1 26 5 18 25 23 15 9 0.85 Highly discriminate
Mtub04 1 26 40 5 32 0.79 Highly discriminate
Mtub21 6 29 26 39 7 15 0.72 Highly discriminate
Mtub30 1 99 1 21 0.33 Moderately discriminate
Mtub39 2 1 22 76 16 2 1 0.59 Moderately discriminate
H value 0.64
Abbreviations: MIRU-VNTR, mycobacterial interspersed repetitive units-variable number of tandem repeats; HGDI, Hunter-Gaston Diversity
Index.
* Discriminatory power indicated as defined by Sola et al. (2003).
Table 5 – Allelic diversity of the MIRU-VNTR loci in CAS vs. other lineages, T-lineage vs. other lineages and in MDR-TB isolates
vs. non MDR-TB.
MIRU-VNTR loci HGDI value of CAS vs.
other lineages
HGDI value of T lineage vs.
other lineages
HGDI value of MDR-TB vs.
non-MDR TB
CAS
lineage
Other
lineages
P-value T-linage Other
lineages
P-value MDR-TB Non-MDR-TB P-value
MIRU4 0.01a 0.2a 0.292 0.06a 0.14a 0.119 0.2a 0.01a 0.284
MIRU10 0.81c 0.77c 0.000* 0.67c 0.81c 0.000* 0.8c 0.77c 0.990
MIRU16 0.46b 0.7c 0.000* 0.6c 0.61c 0.000* 0.73c 0.65c 0.008*
MIRU26 0.69c 0.76c 0.010* 0.71c 0.74c 0.552 0.74c 0.72c 0.066
MIRU31 0.2a 0.26a 0.000* 0.34b 0.55b 0.000* 0.55b 0.62c 0.007*
MIRU40 0.45b 0.73c 0.830 0.56b 0.33b 0.380 0.72c 0.57b 0.015*
ETRA 0.71c 0.74c 0.563 0.62c 0.74c 0.107 0.67c 0.79c 0.243
ETRC 0.12a 0.6c 0.000* 0.46b 0.53b 0.000* 0.66c 0.63c 0.055
Qub11b 0.24a 0.72c 0.000* 0.61c 0.47b 0.000* 0.62c 0.55b 0.062
Qub26 0.32b 0.54b 0.000* 0.32b 0.62c 0.000* 0.67c 0.67c 0.031*
Qub4156 0.88c 0.78c 0.000* 0.58b 0.84c 0.000* 0.82c 0.85c 0.004*
Mtub04 0.68c 0.64c 0.000* 0.45b 0.79c 0.009* 0.76c 0.82c 0.929
Mtub21 0.74c 0.73c 0.000* 0.69c 0.8c 0.007* 0.78c 0.79c 0.317
Mtub30 0.04a 0.48b 0.000* 0.12a 0.39b 0.034* 0.36b 0.31b 0.223
Mtub39 0.31b 0.68c 0.570 0.63c 0.53b 0.000* 0.43b 0.59b 0.944
H value
a Poorly discriminate.
b Moderately discriminate.
c Highly discriminate.
* Statistically significant.
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of spoligotyping (0.992 and 0.930, respectively). For the CAS
strains, HGDI value was 0.82 for spoligotyping and 0.988 for
the MIRU-VNTR, whereas for T strains, HGDI values for spoligo-
typing and MIRU-VNTR were 0.73 and 0.951, respectively. For
the MDR strains, HGDI value for spoligotyping was 0.920, and
its value for MIRU-VNTR was 0.980. Furthermore, the allelic
diversity of each of the 15 MIRU-VNTR loci was calculated to
identify the discriminatory index in each locus [25]. For allstrains, 11 loci were highly discriminate (h > 0.6), 3 moderately
discriminate (Mtub30, Mtub39, MIRU31; 0.3 6 h 6 0.6) and 1 loci
was less polymorphic or poorly discriminate (MIRU4; h < 0.3).
QUB4156 was the most discriminate loci (h = 0.85), whereas
MIRU4 was the least discriminate one (h = 0.1). The mean of
the allelic diversity of 15 loci was 0.65 as measured according
to the method described elsewhere [26].
Ten loci were informative in CAS and T strains as they
were effective in differentiating them from other strains
Fig. 2 – A minimum spanning tree (MST) illustrating evolutionary relationships between the Iraqi M. tuberculosis complex
(MTBC) genotypes: (A) Spoligotypes; (B) MIRU-VNTRs; and (C) Spoligotypes and MIRU-VNTRs pooled together. The tree
connects each genotype based on the degree of changes required to go from one allele to another. The structure of the tree is
represented by branches (continuous vs. dotted lines) and circles representing each individual pattern. Note that the length of
the branches represents the distance between patterns while the complexity of the lines (continuous, black dotted and gray
dotted) denotes the number of allele/spacer changes between two patterns: solid lines, 1 or 2 change (thicker ones indicate a
single change, while the thinner ones indicate 2 changes); dotted lines, three or more changes (black dotted for 3, and grey
dotted for 4 or more changes). The color of the circles is proportional to the number of clinical isolates in this study,
illustrating unique isolates (sky blue) vs. clustered isolates (Blue, 2–5 strains; Dark blue, 6–9 strains; Bordeaux, 10–19 strains;
Red, 20 and more). Note that: (i) spoligotype orphan patterns (n = 5) are marked by the letter ‘‘o’’ in bold red in Fig. 1A; (ii)
patterns with an unknown spoligotyping signature (i.e., unclassified in SITVIT2 database) are marked by an asterisk (*) in
Fig. 1A and C; (iii) five strains without MIRU typing data (strain ID 5291, 6255, 2478, 4826, and 6223 in Supplemental Table S1)
were not included in MSTs shown in Figs. 1B and C.
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Mtub04, Mtub21, Mtub30 (pP 0.05). In addition, one more
locus was informative in each of CAS and T strains (MIRU26
and Mtub39, respectively) (Table 5). Comparison of the allelic
diversity between MDR cases and non-MDR isolates revealed
that MIRU16, MIRU31, MIRU40, QUB26, QIB4156 were statisti-
cally significant in discriminating the MDR cases from
non-MDR cases.
Combination of spoligotyping and MIRU-VNTR data analyses
Fig. 2 shows a minimum spanning tree (MST) illustrating
evolutionary relationships between the Iraqi M. tuberculosis
complex (MTBC) genotypes. MSTs based on the 15 locus
MIRU-VNTR (Fig. 2B) showed a better resolution than spoligo-
typing alone (Fig. 2A). However, the highest discriminatory
power was provided by spoligotyping and MIRU-VNTR used
together (Fig. 2C).
By using MIRU-VNTR the clustering rate was decreased
from 70.8% on spoligotyping to 18.03% on MIRU-VNTR. Many
spoligotyping clusters were subdivided or split into smaller
clusters or into unique patterns; clusters belong to CAS1-
DELHI lineage (n = 50) and ill-defined T lineage (n = 33) were
further subdivided by MIRU-VNTR to 4 clusters with 13 iso-
lates belonging to CAS1-DELHI and 4 clusters with 17 isolates
belonging to ill-defined T genotypes. Notably, SIT1144/T1
cluster (n = 20) was subdivided into 3 smaller clusters contain-
ing 8, 4, 3 isolates/cluster. Similarly, SIT25/CAS1_DELHI clus-
ter (n = 19) was subdivided to one cluster of 2 strains and 17
unique profiles.
Discussion
This report demonstrates the largest amount of molecular
epidemiology data on M. tuberculosis from Iraq to date. Study-
ing the molecular epidemiology of M. tuberculosis clinical iso-
lates may feed a successful TB control program, as this may
unravel the disease transmission dynamics and may high-
light the most successful strains circulating within a popula-
tion in a specific geographical region. In Iraq, data on M.
tuberculosis genotypes are very limited. Thus, genotyping of
M. tuberculosis isolates and determination of predominating
genotypes using spoligotyping and MIRU-VNTR methods
were the aims of this study.
In the current study, spoligotyping of 134M. tuberculosis iso-
lates yielded high clustering rates (70.8%). High clustering rates
were also reported in the neighboring countries, such as Turkey
[11,27] and Saudi Arabia [28]. The basic idea behind identifica-
tion of a cluster is the notion that clustering indicates an ongo-
ing or recent transmission, while unique patterns indicate
reactivation events [23,29]. Nonetheless, spoligotyping is
known to overestimate clustering, and only a systemic sec-
ond-line typing, such as MIRUs, couples with a better tubercu-
losis registry and epidemiological investigations would allow
recognizing the rate of ongoing transmission.
Among 39 spoligotyping patterns observed, 33 patterns
matched preexisting shared types in the international data-
base SITVIT2. One SIT was newly created after matching
with an orphan strain from Iran; this strain was recoveredfrom a patient from Misan Province, which is close to the Ira-
nian borders. Additionally, 5 patterns were new and unique
(orphan). Although orphan strains did not match any pre-
existing SIT, nevertheless, a comparison of their patterns
based on the absence and presence of spacers with that found
in other SITs revealed that these orphans were closely related
to major lineages. These results may suggest that evolving
events have occurred and resulted in the emerging of these
orphan spoligotyping patterns. In contrast to many countries
where extreme dominance of a single lineage is seen, this
study showed that several lineages are in circulation within
Iraqi patients. A specific comparison was also made with
the three ‘‘big’’ neighboring countries of Iraq: Iran, Saudi
Arabia, and Turkey. Results of comparisons showed that even
if more or less of the same lineages are in circulation among
these four countries, each country has its own most predom-
inant lineage(s). Iraq is specific in having its own most
predominant lineage (SIT1144/T1, see below), which is not
found among neighboring countries.
The predominant lineage in this study was the CAS
(42.5%). The CAS lineage is characterized by the absence of
spacer 4–7 and 23–34 [30]. This lineage is reported in many
countries [31,32]; however, the ‘‘high incidence’’ areas of
CAS1 family are the Middle East and Central and Southern
Asia [33–36]. It is identified as a predominant strain in Paki-
stan [32], Delhi [33] and Mumbai, India [37]. In China, CAS1
type is almost exclusively detected in Xinjiang Uygur Auton-
omous Region [38]. Geographically, the Xinjiang region is
adjacent to several Central Asian countries, and they share
similar culture traditions. Historically, those countries, along
with Iraq, are all located along what was called the ‘‘Silk
Road’’ that was the backbone of trading between the Far East
and the Middle East in history [39]. Movements of people and
merchants along this road may have played a major role in
transmission of this strain type between those countries
[40]. Indeed, six clusters belonging to the CAS lineage were
reported in this study. These clusters were of variable sizes,
ranging from 19 isolates (SIT25) to 2 isolates (SIT3371). The
presence of the CAS lineage in big clusters may indicate suc-
cessful circulation of this lineage within the population and
also may implicate inefficiency of the current TB control pro-
gram. Moreover, detecting clusters alongside with unique pat-
terns of strains belonging to the CAS lineage in the Iraqi
population may reflect ongoing evolution events. Further-
more, the majority of SIT25/CAS1_Delhi strains were isolated
from a younger age group–a result that may reflect the recent
spread of this shared type.
The ill-defined T lineage which can be subdivided into 5
sublineages [33], was the 2nd most predominant lineage in
our study (n = 40, 29.9%). The T family genotype prevails in
Africa, Central and South America and Europe [36]. Although
there is no geographic link between Iraq and these regions,
both of the two largest surrounding countries to Iraq, Turkey
and Iran are known to share active borders and historic links
with European countries; therefore, it may be suggested that
the T–family (except SIT1144, see below) may have first
spread in Turkey and/or Iran and then transmitted to Iraq.
Several SITs (clusters) belonging to the T-family were
recorded in this study; notably, SIT1144 was the biggest
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SIT1144/T1 showed the following distribution pattern in the
SITVIT2 database (n = 24 strains in total: Iraq n = 20, USA
n = 2, Venezuela n = 1, Greece n = 1). It is not known whether
there is a link between political displacements and/or war
and the presence of those sporadic strains in USA, Venezuela
and Greece. In this study, SIT1144 is mostly isolated from
younger age groups; A finding that may indicate the recent
spread of this shared type. In addition, 18/20 SIT1144 strains
were MDR, suggesting that this shared type has more propen-
sity to develop multi-drug resistance. SIT284/T1 was repre-
sented in this study by 7 isolates (5.22%). This SIT is
remarkable by the absence of spacers 1–4, 12–13, and 33–36.
Considering the total number of strains in the SITVIT2 data-
base (n = 167), the global proportion of SIT284 strains is more
predominant in Bulgaria (23.95%), followed by Turkey (20.96%)
and Saudi Arabia (13.77%). However, this new Iraqi study
revealed that considering the proportion of the SIT number
per country, SIT284 is present in Iraq in a greater proportion
than the neighboring countries. SIT53 had a significantly
higher proportion in Turkey. This might reflect the transmis-
sion of these isolates between the two countries.
Characterized by the absence of spacers 29-31 and 33-36,
Haarlem and Ural group taken collectively ranked 3rd in our
study (n = 19, 14.2%). Isolates belonging to these lineages have
been reported in several countries, including Iran, Armenia,
Finland, Georgia, and Russia [18]. Indeed, in one study from
Iran, this lineage was the most frequent among the Iranian
population [41]. Looking at the spread of SITs belonging to
the Ural and H families in Iraq and its neighboring countries,
it can be noted that the SIT127 (Ural-2) was significantly more
prevalent in Iran, whereas SIT50 was significantly more pre-
valent in Turkey, and SIT47 was significantly more prevalent
in Iraq. MANU lineage was ranked as the fourth lineage
spreading in Iraq (n = 8, 6%), corresponding to SIT54/MANU2
(6 isolates) and 2 orphans. The MANU2 family has a low prev-
alence worldwide. Indeed, the MANU family is divided into
MANU1 (deletion of spacer 34), MANU2 (deletion of spacers
33–34), and MANU3 (deletion of spacers 34–36). In addition,
a high proportion of drug resistance was found in ST54/
MANU2 genotypes. A similar result was previously reported
in China [42].
The SIT41/Turkey family (previously classified as LAM7-
TUR, but recently shown to be a lineage that does not belong
to the LAM lineage), is probably phylogenetically close to the
X-family of Anglo-Saxon descent as well as the ill-defined T
lineage. Previous studies demonstrated that this shared type
was exclusively isolated in Turkey. [10,11,43–45]. However, in
this study, it was reported that 4 isolates belong to this family.
Several factors may contribute to the spread of this genotype
in Iraq; Turkey had strong historic relationships with Iraq;
indeed, Iraq was a part of the Ottoman Empire. There is a
Turkish ethnic minority in Iraq, and there is continuous pop-
ulation movement between those two countries for trading,
tourism and immigration. Moreover, three fourths (75%) of
the SIT41 strains were MDR; this is inconsistent with the
study of Kisa et al. [10] who found that this shared type is
associated with drug resistance. LAM lineage was represented
in this study by three isolates (2.2%) corresponding to SIT 29
(n = 12) and SIT64 (n = 1). LAM lineage prevails in SouthernEurope, Africa [18] and South America [46]. In Saudi Arabia
and Turkey, 7.2% and 5.3%, respectively, of the strains were
attributed to LAM lineages [10,28]; therefore, it is not surpris-
ing to report this lineage in Iraq.
Regarding age and gender of patients, two notable features
were emerging within the two largest clusters (SIT1144 and
SIT25); first, the majority of isolates were from younger age
groups (<35 years old); second, in contrast to the whole set
of isolates, there was almost an equal male to female ratio
seen in those 2 clusters. By assuming that clusters arise from
recent transmission rather than reactivation, this may
explain the discrepancy in male to female ratio as a propor-
tion of disease from reactivation that is occurring in males
more than females.
The clustering rate among the MDR strains was 65.7%,
which is comparable with the full set of isolates. Around
one quarter (25.7%, n = 18) of the MDR cases was attributed
to the SIT1144/T1; therefore, it seems that this SIT may have
a propensity to be MDR. This is an alarming result, and fur-
ther studying of this SIT is required, as well as the monitoring
of its spread is recommended. In addition, other strains have
also showed a propensity toward MDR, such as SIT50/H3 (6/
6,100%), SIT247 (4/5, 80), SIT41 (3/4, 75%), and SIT29 (2/2,
100%). Drug resistance was also reported in these strains in
Turkey [47]. High percentages of MDR within certain geno-
typic lineages were also reported in several studies [48]. How-
ever, the proportions of MDR cases were higher in this study,
and this may be due to the fact that these cases are biased
toward treatment failure. In contrary, certain SITs showed
the opposite trend; for instance, all SIT1198 (6/6) and SIT47/
H1 (4/4) strains, in addition to the majority of SIT54 (7/8)
strains were non-MDR. Furthermore, a significant association
was found between DST results and gender (females associ-
ated with MDR [P = 0.02]). Previous studies reported an associ-
ation between TB infection and other demographic factors
like young age [23,49], and drug resistance [49].
A spoligoforest was constructed to visualize the relation-
ships among spoligotypes reported in this study. Spoligoforest
is a tool to recover the history of transmission and mutation
events [50]. As shown in Fig. 2, several large spoligotype nodes
were reported in this study, including SIT1144, SIT25, SIT22,
SIT284. . .etc. These shared types may have been transmitted
extensively over a long period of time. The SIT53 has the larg-
est number of descendent/outbounds (n = 9), followed by the
SIT26 (n = 6); this implies that those strains have had a long
period of time over which they generated mutations. In addi-
tion, as shown in Fig. 2A, certain shared types (such as SIT26,
SIT54, SIT284) are located in the upper layouts and thus they
potentially represent the oldest spoligotype in this forest. Fur-
thermore, the SIT26 has a large node size yet positioned at a
tip of the spoligoforest; this may indicate that the strain
within this spoligotype are being transmitted faster than
other strains in this data set [51]. The SIT1144, SIT50, and
SIT1198 are present in the down layouts and could therefore
be ‘‘emerging strains’’. In line with this finding, MIRU-VNTR
showed a high strain homogeneity among the strains of the
SIT1144; this suggests once again that SIT1144 may be
associated with a higher transmission rate than other strains.
However, further quantitative analyses are required to verify
this point.
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not highlighted in spoligoforests (Fig. 1), one may notice some
similarities between these two patterns. Indeed, only two
changes differentiate these spoligotypes: SIT1144 is defined
by the presence of spacer 20 and the absence of spacer 25
as opposed to SIT41, which is defined by the absence of spacer
20 and the presence of spacer 25. Like LAM lineage’s signa-
ture, SIT41 is characterized by the absence of spacers 21–24
and spacers 33–36. However, contrary to the traditional LAM
signature, spacer 25 is absent in the SIT1144 signature. Hence,
further studies on a finer characterization of SIT41 and
SIT1144 might help understand the reasons for its predomi-
nance in this study vs. its absence in neighboring countries,
as well as the naming/renaming of the LAM7-TUR/Turkey
lineage(s). It is noteworthy that the 15-loci MIRUs did not
underline any direct link between SIT41 and SIT1144 in this
study (Supplemental Table S1).
There was a high diversity of MIRU-VNTR patterns among
the isolates in this study; 100 distinct profiles were detected
corresponding to 92 orphan profiles and 8 MIT clusters each
with 2–8 isolates/cluster. The clustering rate was 18.03% (see
Supplemental Table S2), implying that the minimum estimate
of disease related to recent transmission was 18.3%. Despite
the fact that MIRU-VNTR typing revealed decreased clustering
rates compared with spoligotyping, preliminary MIRU-VNTR
analyses suggest that all of the most common spoligotype
clusters, except SIT25 and SIT50, contain MIRU patterns with
high profile homogeneity (less than 3 loci difference, 80% or
more homogeneity) even if the strains had been isolated at
distinct geographic regions of Iraq, suggesting that those SITs
comprise clonal groups of strains. These results implicate
that all spoligotype clusters, except SIT25 and SIT50, may rep-
resent large clonal clusters. Several studies have reported that
some MIRU loci have faster molecular clocks [16,52–54], which
could explain the single locus variations between isolates
linked to an ongoing transmission. Furthermore, all of the
isolates that were classified as unique by spoligotyping were
shown to be orphans by MIRU-VNTR. If this is true, the major-
ity of these spoligotype clusters could be linked to the trans-
mission process. Accordingly, SIT25 and SIT50 contained
different strain genotypes and thus are less likely to be linked
to recent transmission. It is noteworthy that the majority of
strains within MIRU clusters were isolated in the same geo-
graphic regions; this may represent an epidemiological link.
Furthermore, most of the clusters were involving more than
two strains (5/8). It is generally assumed that the detection
of links in a transmission chain involving a substantial num-
ber of cases produce higher yields. These results may indicate
that geographic regions could explain the majority of the
MIRU-VNTR clusters. Of note, most cluster strains were from
Baghdad; this may be because Baghdad is the most populated
province amongst the 18 provinces of Iraq (being inhabited by
almost one third of the total Iraqi population). The geographic
explanation of the MIRU-VNTR clusters in this study may
confirm the value of MIRU-VNTR identification of transmis-
sion events.
Notably, the SIT1144/T1 was divided into three smaller
clusters by MIRU-VNTR typing that only differ in 1 or 2 loci.
These results suggest SIT1144 might represent a clonal group
of strains. In addition, analysis of the geographic distributionof SIT1144 strains shows that they were isolated in different
regions in Iraq. Thus, SIT1144 strains seem to have selective
advantages over other strains in their ability to cause disease
and be transmitted.
Evidence suggests that the choice of appropriate loci for
MIRU-VNTR may require evaluation in diverse MTB lineages
in countries with a high TB prevalence [55,56]. HGDI calcula-
tions revealed that the discriminatory power of the MIRU-
VNTR was higher than that of spoligotyping, 0.992 and 0.93,
respectively. This confirms that MIRU-VNTR typing is most
suited for the study of molecular diversity of M. tuberculosis
isolates.
For combined spoligotyping and MIRU-VNTR analysis, iso-
lates with identical SIT and MIT profiles were categorized as
‘‘cluster,’’ whereas ‘‘unique’’ profiles were reported for single
isolates. Combined spoligotyping and MIRU-VNTR analysis
classified 30 strains into 2 major clades: ill-defined T (17 iso-
lates clustered into 4 clusters) and CAS1-DELHI (13 isolates
clustered into 4 clusters).
In addition, the allelic diversity was calculated for each
locus in 15-MIRU-VNTR within three formats: (a) within whole
study strains; (b) within MDR cases; and (c) within the 2 largest
lineages (CAS and T). MIRU16, MIRU31, MIRU40, QUB26, and
QIB4156 had a significantly higher discriminatory index with
P value <0.05 and thus efficient in discriminating the MDR
cases from the non-MDR strains; MIRU10, MIRu16, MIRU26,
MIRU31, ETR-C, QUB11b, QUB26, QUB4156, Mtub04, Mtub21,
and Mtub30 significantly discriminated CAS from non-CAS
strains; and MIRU10, MIRU16, MIRU31, ETR-C, QUB11b,
QUB26, QUB4156, Mtub04, Mtub21, Mtub30, and Mtub39 were
able to significantly discriminate between the Tand non-T iso-
lates. HGDI (spoligotyping and MIRU-VNTR) for both T and
CAS1-DELHI were (0.82 and 0.988), and (0.73 and 0.951), respec-
tively. The clustering rates within the predominant lineages in
Iraq were 80.7% for CAS and 72.5% for T. This might reflect that
isolates belonging to these two lineages are more actively
transmitted than other isolates. Despite MIRU-VNTR typing
splits the CAS and T spoligotype SIT into non-clustered pro-
files, the differences between MIRU profiles does not exceed 3
loci (except SIT25- which seems to be more polymorphic). This
might be a result of intrinsic similarity or due to reflective relat-
edness within CAS and T lineages.Conclusions
TB in Iraq is occurring in younger age groups with twice as
many males than females. In contrast to many countries
where extreme dominance of a single lineage is seen, this
study showed that several lineages are in circulation within
Iraqi patients. The predominant lineage was CAS (42.5%), fol-
lowed by the ill-defined T (29.9%). This was expected as those
2 lineages are common isolates in the neighboring countries.
In addition, there were other lineages that were well repre-
sented among these isolates, such as Haarlem (14.2%; split
in Haarlem sensu-stricto 9.7%, and Ural 4.48%), and MANU
(6%). It is noteworthy, the Turkey lineage, that previously
reported to be exclusively isolated in Turkey, was represented
in this study by four isolates (3%). Surprisingly, the Beijing
family–the worldwide distributed group of strains–was not
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served from the transmission of this problematic family of
strains. A comparison of the spoligotypes in this study with
the three ‘‘big’’ neighboring countries of Iraq–Iran, Saudi Ara-
bia, and Turkey–showed that if more or less the same lineages
are in circulation among these four countries, each country
has its own most predominant lineage(s). Iraq is unique in
having its own most predominant lineage (SIT1144/T1), which
is not found among neighboring countries. This shared type
has more propensities for multi-drug resistance.
Highly diverse MIRU-VNTR genotypes were displayed; 100
distinct MIRU-VNTR genotypes were detected (8 clusters with
2–8 strains/cluster and 92 unique). The clustering rate was
18.03%. The discriminatory efficiency of MIRU-VNTR was high
(HGDI 0.992); it was higher than that of spoligotyping (HGDI
0.930). This high resolution was due to the fact that 14/15 loci
were highly to moderately discriminate (h > 0.6, and h > 0.3,
respectively) and the mean of the allelic diversity of the 15
loci was high (0.65). The minimum spanning tree (MST)
showed a better resolution by MIRU-VNTR than by spoligotyp-
ing alone. However, the highest discriminatory power was
provided by spoligotyping and MIRUs together. Owing to the
low clustering rate by MIRU-VNTR, these results suggest that
drug-resistant TB in Iraq is due to acquired resistance as
opposed to transmission.
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